Overcoming therapeutic MAb resistance in agressive HER2 positive breast carcinomas by adoptive immunotherapy using optizimed effectors cells
Sandrine Valsesia-Wittmann, Beatrice Clemenceau, Anne-Catherine Jallas, Jean-Yves Blay, Aurelien Marabelle, Christophe Caux, Henri Vie
Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P176; DOI: 10.1186/2051-1426-1-S1-P176
